THAO NGUYEN: Open Payments
NPI 1407522105 · CLIVE, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$357 in 15 payments from 8 companies in 2025. Trend: 2023 $752 · 2024 $1,137 · 2025 $357
Food & beverage: $258Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 1 | $99 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $64 |
| ABBVIE INC. | 3 | $58 |
| Celltrion USA Inc. | 2 | $50 |
| Gilead Sciences, Inc. | 1 | $28 |
| Phathom Pharmaceuticals, Inc. | 3 | $25 |
| PFIZER INC. | 1 | $18 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
Products named: STELARA, XIFAXAN, RINVOQ, VEGZELMA, VOQUEZNA, VELSIPITY, DUPIXENT.
Industry payments across IA — which companies pay providers there.
